{"id":"https://openalex.org/W2969411997","doi":"https://doi.org/10.1007/s13300-019-00680-5","title":"Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes","display_name":"Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes","alternate_titles":[],"publication_year":2019,"publication_date":"2019-08-22","ids":{"openalex":"https://openalex.org/W2969411997","doi":"https://doi.org/10.1007/s13300-019-00680-5","mag":"2969411997","pmid":"https://pubmed.ncbi.nlm.nih.gov/31440988","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6778572"},"language":"en","primary_location":{"id":"doi:10.1007/s13300-019-00680-5","doi":"https://doi.org/10.1007/s13300-019-00680-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-019-00680-5","pdf_url":null,"source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2969411997"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1007/s13300-019-00680-5","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034942182","display_name":"Taichi Nagahisa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Taichi Nagahisa","raw_affiliation_strings":["Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013836607","display_name":"Yoshifumi Saisho","orcid":"https://orcid.org/0000-0002-6071-4393","observed_orcids":["https://orcid.org/0000-0002-6071-4393"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoshifumi Saisho","raw_affiliation_strings":["Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. ysaisho@keio.jp","Division of Endocrinology, Metabolism and Nephrology, Department of\nInternal Medicine, Keio University School of Medicine, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0002-6071-4393","affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. ysaisho@keio.jp","institution_ids":["https://openalex.org/I203951103"]},{"raw_affiliation_string":"Division of Endocrinology, Metabolism and Nephrology, Department of\nInternal Medicine, Keio University School of Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5013836607"],"corresponding_institution_ids":["https://openalex.org/I203951103"],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":1.5416,"has_fulltext":false,"cited_by_count":94,"citation_normalized_percentile":{"value":0.8349835,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"10","issue":"5","first_page":"1733","last_page":"1752"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9300000071525574},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cardiorenal-protection","display_name":"cardiorenal protection","score":0.925000011920929},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.7559999823570251},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.925000011920929},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.7960000038146973},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.5879999995231628},{"id":"https://openalex.org/keywords/glucose-lowering-agents","display_name":"glucose-lowering agents","score":0.6729999780654907},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.6809999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9228440523147583},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.793419361114502},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.733522891998291},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.644916832447052},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.5623610019683838},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.516377329826355},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49804162979125977},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4535253643989563},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.41446438431739807},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.41307318210601807},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3825218379497528},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.2509027421474457},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.14516055583953857}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1007/s13300-019-00680-5","doi":"https://doi.org/10.1007/s13300-019-00680-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-019-00680-5","pdf_url":null,"source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},{"id":"pmid:31440988","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31440988","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes therapy : research, treatment and education of diabetes and related disorders","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6778572","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6778572/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s13300-019-00680-5","doi":"https://doi.org/10.1007/s13300-019-00680-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-019-00680-5","pdf_url":null,"source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320317302","display_name":"Boehringer Ingelheim Japan","ror":"https://ror.org/02r1d7x68"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":105,"referenced_works":["https://openalex.org/W172609984","https://openalex.org/W1525396932","https://openalex.org/W1526927233","https://openalex.org/W1955935325","https://openalex.org/W1957004156","https://openalex.org/W1988049600","https://openalex.org/W1990025047","https://openalex.org/W1996042816","https://openalex.org/W2002757015","https://openalex.org/W2021517048","https://openalex.org/W2037163857","https://openalex.org/W2040580117","https://openalex.org/W2043900831","https://openalex.org/W2045188930","https://openalex.org/W2049155190","https://openalex.org/W2054981500","https://openalex.org/W2064130493","https://openalex.org/W2087682588","https://openalex.org/W2098083442","https://openalex.org/W2103274121","https://openalex.org/W2104252114","https://openalex.org/W2111876001","https://openalex.org/W2113507924","https://openalex.org/W2117764934","https://openalex.org/W2118613762","https://openalex.org/W2127125241","https://openalex.org/W2127854619","https://openalex.org/W2138077952","https://openalex.org/W2142830692","https://openalex.org/W2146264128","https://openalex.org/W2148254941","https://openalex.org/W2150392479","https://openalex.org/W2152984355","https://openalex.org/W2153839551","https://openalex.org/W2155287847","https://openalex.org/W2158666727","https://openalex.org/W2160088494","https://openalex.org/W2170606300","https://openalex.org/W2188846692","https://openalex.org/W2211492625","https://openalex.org/W2273849019","https://openalex.org/W2282578582","https://openalex.org/W2302447233","https://openalex.org/W2315065708","https://openalex.org/W2337454357","https://openalex.org/W2340643800","https://openalex.org/W2341611738","https://openalex.org/W2412800896","https://openalex.org/W2416348735","https://openalex.org/W2424539745","https://openalex.org/W2425644022","https://openalex.org/W2441833121","https://openalex.org/W2443999297","https://openalex.org/W2505843168","https://openalex.org/W2519510391","https://openalex.org/W2519803668","https://openalex.org/W2528138059","https://openalex.org/W2542456927","https://openalex.org/W2559954620","https://openalex.org/W2594305555","https://openalex.org/W2606513490","https://openalex.org/W2607109151","https://openalex.org/W2607447455","https://openalex.org/W2613347927","https://openalex.org/W2619772777","https://openalex.org/W2626446274","https://openalex.org/W2711994541","https://openalex.org/W2733849831","https://openalex.org/W2750589886","https://openalex.org/W2752707491","https://openalex.org/W2754041380","https://openalex.org/W2763508675","https://openalex.org/W2765097799","https://openalex.org/W2767936163","https://openalex.org/W2773969925","https://openalex.org/W2774157762","https://openalex.org/W2785139619","https://openalex.org/W2786752552","https://openalex.org/W2788154323","https://openalex.org/W2792252004","https://openalex.org/W2793397887","https://openalex.org/W2808008353","https://openalex.org/W2808317629","https://openalex.org/W2808467887","https://openalex.org/W2809136812","https://openalex.org/W2809329973","https://openalex.org/W2884466498","https://openalex.org/W2894627590","https://openalex.org/W2894746763","https://openalex.org/W2894993577","https://openalex.org/W2899764361","https://openalex.org/W2900149048","https://openalex.org/W2900413769","https://openalex.org/W2902527999","https://openalex.org/W2913004143","https://openalex.org/W2916835086","https://openalex.org/W2921723272","https://openalex.org/W2923860159","https://openalex.org/W2934651013","https://openalex.org/W2939222610","https://openalex.org/W2948229227","https://openalex.org/W2948519518","https://openalex.org/W2948612418","https://openalex.org/W4206445899","https://openalex.org/W4212810717"],"related_works":["https://openalex.org/W4313401342","https://openalex.org/W3212713672","https://openalex.org/W4385420982","https://openalex.org/W4381730774","https://openalex.org/W3181586533","https://openalex.org/W4403231191","https://openalex.org/W4394687906","https://openalex.org/W2973359600","https://openalex.org/W7134268964","https://openalex.org/W3173421961"],"abstract_inverted_index":{"Recent":[0],"large":[1],"clinical":[2,99,136],"trials":[3,131],"on":[4,32],"sodium-glucose":[5],"cotransporter":[6],"2":[7,49],"(SGLT2)":[8],"inhibitors":[9,140],"and":[10,41,64,83,98,132,141,162,170],"glucagon-like":[11],"peptide-1":[12],"(GLP-1)":[13],"receptor":[14,118,143],"agonists,":[15],"with":[16,47,60,96,103,109,168],"the":[17,61,65,73,78,84,88,125,134,156],"aim":[18],"of":[19,38,43,90,127,138,150,158],"verifying":[20],"cardiovascular":[21,34,100,129,160],"safety,":[22],"have":[23,28],"revealed":[24],"that":[25,94],"these":[26,151],"medications":[27],"a":[29],"preventative":[30],"advantage":[31,137],"adverse":[33,159],"outcomes,":[35],"including":[36],"worsening":[37],"heart":[39],"failure":[40],"deterioration":[42],"nephropathy,":[44],"in":[45,166],"patients":[46,95,167],"type":[48],"diabetes":[50],"(T2D).":[51],"These":[52],"observed":[53],"benefits":[54],"do":[55],"not":[56],"seem":[57],"to":[58],"correlate":[59],"glucose-lowering":[62,152],"effect,":[63],"underlying":[66],"mechanism":[67],"is":[68],"being":[69],"intensively":[70],"investigated.":[71],"Given":[72],"results":[74,126],"from":[75],"recent":[76,128],"studies,":[77],"American":[79],"Diabetes":[80,91],"Association":[81,86],"(ADA)":[82],"European":[85],"for":[87,154],"Study":[89],"(EASD)":[92],"recommend":[93],"T2D":[97,169],"disease":[101],"(CVD)":[102],"inadequate":[104],"glucose":[105],"control":[106],"despite":[107],"treatment":[108],"metformin":[110],"should":[111],"receive":[112],"an":[113],"SGLT2":[114,139],"inhibitor":[115],"or":[116],"GLP-1":[117,142],"agonist.":[119],"In":[120],"this":[121],"review":[122],"we":[123],"summarize":[124],"outcome":[130],"discuss":[133],"potential":[135],"agonists.":[144],"We":[145],"also":[146],"present":[147],"practical":[148],"implications":[149],"agents":[153],"reducing":[155],"risk":[157],"events":[161],"progressive":[163],"renal":[164],"comorbidity":[165],"CVD.":[171]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2969411997","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":27},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":4}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2019-08-29T00:00:00"}
